First Page | Document Content | |
---|---|---|
![]() Fertility In vitro fertilisation Preimplantation genetic diagnosis Ovarian hyperstimulation Transvaginal oocyte retrieval Human chorionic gonadotropin Assisted reproductive technology Gonadotropin-releasing hormone antagonist Gonadotropin-releasing hormone agonist Fertility medicine Human reproduction Medicine | Add to Reading List |
![]() | ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.DocID: 16voX - View Document |
![]() | IVF/GIFT Elonva® applications Purpose of this form Filling in this formDocID: UsX0 - View Document |
![]() | SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by theDocID: JtWT - View Document |
![]() | SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by theDocID: ISkM - View Document |
![]() | SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by theDocID: IJbr - View Document |